1 ML medroxyprogesterone acetate 150 MG/ML Injection

RxCUI: 1000126
RxNorm name: 1 ML medroxyprogesterone acetate 150 MG/ML Injection
Display name: medroxyPROGESTERone (Injectable)
Full name: 1 ML medroxyprogesterone acetate 150 MG/ML Injection
Term type: SCD
Status: Active
Strength: 150 mg/ml
Dose form: Injection 1 ml
Route: Injectable
Updated: 2026-10-21 07:26:25

RxNorm Status History#

Status: Active
Source: RXNORM
Current: YES
Release start: 092010
Active start: 092010
Multiple ingredient: NO
Branded: NO

Ingredients And Strength#

Ingredient, Strength, Base table
Ingredient	Strength	Base	Basis of strength
medroxyprogesterone acetate	150 MG / 1 ML	medroxyprogesterone	medroxyprogesterone acetate

Dose Form Concepts#

Dose form, RxCUI table
Dose form	RxCUI
Injection	1649574

Derived Ingredient Concepts#

Ingredient, RxCUI table
Ingredient	RxCUI
medroxyprogesterone	6691

Source Vocabulary Codes#

Code type, Values, Count table
Code type	Values	Count	Category
PRESCRIBABLE	Y	1	ATTRIBUTES
RXNAV_STR	1 ML medroxyPROGESTERone acetate 150 MG/ML Injection	1	NAMES
RxNorm Name	1 ML medroxyprogesterone acetate 150 MG/ML Injection	1	NAMES
RxNorm Synonym	medroxyprogesterone acetate 150 MG per 1 ML Injection	1	NAMES
TTY	SCD	1	ATTRIBUTES
SPL_SET_ID	10 linked values 5e817926-ba15-4d16-9463-88f6ff3bd3ac 60aba812-59eb-4d40-9b6b-d135dca9d36b 0476eac5-d96c-4910-aa86-1ddeeefefe50 6457d70a-2f25-4935-8511-726d988f7a03 24544a5d-0cf5-a099-b57c-6e0843a40532 0655670a-d127-4e08-8a23-ace64b2503b2 987496bf-b4b0-409b-b745-f52ed0871f4e a80560e1-96dd-4380-b3e1-d52719ccdd4b d1ea4098-6196-421f-b8e1-bcb31a061e04 fda1aa8a-5739-482a-b4f6-9741ef4d9977	10	CODES
RxCUI	1000126	1	CODES
MMSL_CODE	2 linked values CD1843 MTH_RXN_BD1843	2	CODES

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDC	Product NDC	Name	Labeler	Application
0548-5400-00	0548-5400	Medroxyprogesterone Acetate Medroxyprogesterone acetate	Amphastar Pharmaceuticals, Inc.	ANDA077235
0548-5400-25	0548-5400	Medroxyprogesterone Acetate Medroxyprogesterone acetate	Amphastar Pharmaceuticals, Inc.	ANDA077235
24201-150-01	24201-150	Medroxyprogesterone Acetate Injectable Suspension medroxyprogesterone acetate	Hikma Pharmaceuticals USA Inc.	ANDA214309
24201-150-25	24201-150	Medroxyprogesterone Acetate Injectable Suspension medroxyprogesterone acetate	Hikma Pharmaceuticals USA Inc.	ANDA214309
50090-5619-0	50090-5619	medroxyprogesterone acetate medroxyprogesterone acetate	A-S Medication Solutions	NDA020246
55150-329-01	55150-329	MEDROXYPROGESTERONE ACETATE MEDROXYPROGESTERONE ACETATE	Eugia US LLC	ANDA212824
55150-329-25	55150-329	MEDROXYPROGESTERONE ACETATE MEDROXYPROGESTERONE ACETATE	Eugia US LLC	ANDA212824
60219-1467-1	60219-1467	Medroxyprogesterone Acetate Medroxyprogesterone Acetate	Amneal Pharmaceuticals NY LLC	ANDA210227
60219-1467-2	60219-1467	Medroxyprogesterone Acetate Medroxyprogesterone Acetate	Amneal Pharmaceuticals NY LLC	ANDA210227
62756-090-40	62756-090	MEDROXYPROGESTERONE ACETATE MEDROXYPROGESTERONE ACETATE	Sun Pharmaceutical Industries, Inc.	ANDA210760
62756-090-45	62756-090	MEDROXYPROGESTERONE ACETATE MEDROXYPROGESTERONE ACETATE	Sun Pharmaceutical Industries, Inc.	ANDA210760
66993-370-25	66993-370	medroxyprogesterone acetate medroxyprogesterone acetate	Prasco Laboratories	NDA020246
66993-370-83	66993-370	medroxyprogesterone acetate medroxyprogesterone acetate	Prasco Laboratories	NDA020246
67457-887-01	67457-887	Medroxyprogesterone Acetate Medroxyprogesterone Acetate	Mylan Institutional LLC	ANDA210227
67457-887-99	67457-887	Medroxyprogesterone Acetate Medroxyprogesterone Acetate	Mylan Institutional LLC	ANDA210227
70121-1467-2	70121-1467	medroxyprogesterone acetate medroxyprogesterone acetate	Amneal Pharmaceuticals LLC	ANDA215397
70121-1467-5	70121-1467	medroxyprogesterone acetate medroxyprogesterone acetate	Amneal Pharmaceuticals LLC	ANDA215397
70700-315-25	70700-315	Medroxyprogesterone Acetate Medroxyprogesterone Acetate	Xiromed LLC	ANDA210227
70700-315-27	70700-315	Medroxyprogesterone Acetate Medroxyprogesterone Acetate	Xiromed LLC	ANDA210227

Drugs@FDA Applications#

Application, NDC, Name table
Application	NDC	Name	Marketing category	Labeler
ANDA077235	0548-5400	Medroxyprogesterone Acetate Medroxyprogesterone acetate	ANDA	Amphastar Pharmaceuticals, Inc.
ANDA214309	24201-150	Medroxyprogesterone Acetate Injectable Suspension medroxyprogesterone acetate	ANDA	Hikma Pharmaceuticals USA Inc.
NDA020246	50090-5619	medroxyprogesterone acetate medroxyprogesterone acetate	NDA AUTHORIZED GENERIC	A-S Medication Solutions
ANDA212824	55150-329	MEDROXYPROGESTERONE ACETATE MEDROXYPROGESTERONE ACETATE	ANDA	Eugia US LLC
ANDA210227	60219-1467	Medroxyprogesterone Acetate Medroxyprogesterone Acetate	ANDA	Amneal Pharmaceuticals NY LLC
ANDA210760	62756-090	MEDROXYPROGESTERONE ACETATE MEDROXYPROGESTERONE ACETATE	ANDA	Sun Pharmaceutical Industries, Inc.
ANDA215397	70121-1467	medroxyprogesterone acetate medroxyprogesterone acetate	ANDA	Amneal Pharmaceuticals LLC

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 76 matching rows.

NDC11, Source, Active table
NDC11	Source	Active
00247210801	rxnav_ndcs	yes
00548540000	rxnav_ndcs	yes
00548540025	rxnav_ndcs	yes
00548540125	rxnav_ndcs	yes
00548541000	rxnav_ndcs	yes
00548541025	rxnav_ndcs	yes
00703680101	rxnav_ndcs	yes
16714002801	rxnav_ndcs	yes
16714098101	rxnav_ndcs	yes
16714098102	rxnav_ndcs	yes
24201015000	rxnav_ndcs	yes
24201015001	rxnav_ndcs	yes
24201015025	rxnav_ndcs	yes
50090088300	rxnav_ndcs	yes
50090425100	rxnav_ndcs	yes
50090561900	rxnav_ndcs	yes
55150032901	rxnav_ndcs	yes
55150032925	rxnav_ndcs	yes
59762453701	rxnav_ndcs	yes
59762453702	rxnav_ndcs	yes
60219146701	rxnav_ndcs	yes
60219146702	rxnav_ndcs	yes
62756009040	rxnav_ndcs	yes
62756009045	rxnav_ndcs	yes
63629874401	rxnav_ndcs	yes
66993037025	rxnav_ndcs	yes
66993037083	rxnav_ndcs	yes
67457088700	rxnav_ndcs	yes
67457088701	rxnav_ndcs	yes
67457088799	rxnav_ndcs	yes
69097053931	rxnav_ndcs	yes
70121146702	rxnav_ndcs	yes
70121146705	rxnav_ndcs	yes
70700031522	rxnav_ndcs	yes
70700031525	rxnav_ndcs	yes
70700031527	rxnav_ndcs	yes
00009074631	rxnav_historical_indirect
00009074634	rxnav_historical_indirect
00009453701	rxnav_historical
00009453702	rxnav_historical
00009737606	rxnav_historical_indirect
00009737698	rxnav_historical_indirect
00009737699	rxnav_historical_indirect
00247059101	rxnav_historical_indirect
00703680104	rxnav_historical
00703681121	rxnav_historical_indirect
00703681122	rxnav_historical
00703681124	rxnav_historical
10835010101	rxnav_historical
16714002825	rxnav_historical
23490585401	rxnav_historical
52125064001	rxnav_historical
52125091501	rxnav_historical
54569370100	rxnav_historical_indirect
54569490400	rxnav_historical_indirect
54569552700	rxnav_historical_indirect
54569561600	rxnav_historical
54868361300	rxnav_historical_indirect
54868410000	rxnav_historical_indirect
54868410001	rxnav_historical_indirect
54868525700	rxnav_historical
55045350501	rxnav_historical_indirect
59267453701	rxnav_historical
59267453702	rxnav_historical
59267453801	rxnav_historical
59267737601	rxnav_historical_indirect
59267737602	rxnav_historical_indirect
59267737603	rxnav_historical_indirect
59267737604	rxnav_historical_indirect
63704090501	rxnav_historical
68071181805	rxnav_historical
68071466605	rxnav_historical
68788064201	rxnav_historical
68788923301	rxnav_historical
70518432400	rxnav_historical
71205011801	rxnav_historical

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 12 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
medroxyprogesterone acetate	MEDROXYPROGESTERONE ACETATE	REMEDYREPACK INC.	a0a92717-c1cb-40eb-a95a-1c5dfd32cfc0	2026-09-04	Boxed warning, Warnings, Adverse reactions	Exact identifier ndc11 (package): 70518432400
medroxyprogesterone acetate	MEDROXYPROGESTERONE ACETATE	Prasco Laboratories	987496bf-b4b0-409b-b745-f52ed0871f4e	2026-08-25	Boxed warning, Warnings, Adverse reactions	Exact identifier ndc (package): 66993-370-25 ndc (package): 66993-370-83 ndc (product): 66993-370 ndc11 (package): 66993037025 ndc11 (package): 66993037083 rxcui: 1000126
Depo-Provera	MEDROXYPROGESTERONE ACETATE	Pharmacia & Upjohn Company LLC	199cf13e-0859-4a73-9b45-e700d0cd1049	2026-08-25	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 1000126
medroxyprogesterone acetate	MEDROXYPROGESTERONE ACETATE	A-S Medication Solutions	5e817926-ba15-4d16-9463-88f6ff3bd3ac	2026-02-23	Boxed warning, Warnings, Adverse reactions	Exact identifier ndc (package): 50090-5619-0 ndc (product): 50090-5619 ndc11 (package): 50090561900 rxcui: 1000126
Medroxyprogesterone Acetate	MEDROXYPROGESTERONE ACETATE	Xiromed LLC	24544a5d-0cf5-a099-b57c-6e0843a40532	2026-02-13	Boxed warning, Warnings, Adverse reactions	Exact identifier ndc (package): 70700-315-27 ndc (package): 70700-315-25 ndc (product): 70700-315 ndc11 (package): 70700031522 ndc11 (package): 70700031525 ndc11 (package): 70700031527 rxcui: 1000126
medroxyprogesterone acetate	MEDROXYPROGESTERONE ACETATE	Amneal Pharmaceuticals LLC	6457d70a-2f25-4935-8511-726d988f7a03	2026-01-19	Boxed warning, Warnings, Adverse reactions	Exact identifier ndc (package): 70121-1467-2 ndc (package): 70121-1467-5 ndc (product): 70121-1467 ndc11 (package): 70121146702 ndc11 (package): 70121146705 rxcui: 1000126
MEDROXYPROGESTERONE ACETATE	MEDROXYPROGESTERONE ACETATE	Eugia US LLC	0655670a-d127-4e08-8a23-ace64b2503b2	2026-01-08	Boxed warning, Warnings, Adverse reactions	Exact identifier ndc (package): 55150-329-25 ndc (package): 55150-329-01 ndc (product): 55150-329 ndc11 (package): 55150032925 ndc11 (package): 55150032901 rxcui: 1000126
Medroxyprogesterone Acetate	MEDROXYPROGESTERONE ACETATE	Amphastar Pharmaceuticals, Inc.	fda1aa8a-5739-482a-b4f6-9741ef4d9977	2026-01-01	Boxed warning, Warnings, Adverse reactions	Exact identifier ndc (package): 0548-5400-00 ndc (package): 0548-5400-25 ndc (product): 0548-5400 ndc11 (package): 00548540000 ndc11 (package): 00548540025 rxcui: 1000126
Medroxyprogesterone Acetate	MEDROXYPROGESTERONE ACETATE	Amneal Pharmaceuticals NY LLC	a80560e1-96dd-4380-b3e1-d52719ccdd4b	2025-02-07	Boxed warning, Warnings, Adverse reactions	Exact identifier ndc (package): 60219-1467-2 ndc (package): 60219-1467-1 ndc (product): 60219-1467 ndc11 (package): 60219146701 ndc11 (package): 60219146702 rxcui: 1000126
Medroxyprogesterone Acetate Injectable Suspension	MEDROXYPROGESTERONE ACETATE	Hikma Pharmaceuticals USA Inc.	0476eac5-d96c-4910-aa86-1ddeeefefe50	2025-01-08	Boxed warning, Warnings, Adverse reactions	Exact identifier ndc (package): 24201-150-01 ndc (package): 24201-150-25 ndc (product): 24201-150 ndc11 (package): 24201015001 ndc11 (package): 24201015000 ndc11 (package): 24201015025 rxcui: 1000126
MEDROXYPROGESTERONE ACETATE	MEDROXYPROGESTERONE ACETATE	Sun Pharmaceutical Industries, Inc.	d1ea4098-6196-421f-b8e1-bcb31a061e04	2021-06-29	Boxed warning, Warnings, Adverse reactions	Exact identifier ndc (package): 62756-090-45 ndc (package): 62756-090-40 ndc (product): 62756-090 ndc11 (package): 62756009045 ndc11 (package): 62756009040 rxcui: 1000126
Medroxyprogesterone Acetate	MEDROXYPROGESTERONE ACETATE	Mylan Institutional LLC	60aba812-59eb-4d40-9b6b-d135dca9d36b	2021-03-12	Boxed warning, Warnings, Adverse reactions	Exact identifier ndc (package): 67457-887-99 ndc (package): 67457-887-01 ndc (product): 67457-887 ndc11 (package): 67457088799 ndc11 (package): 67457088700 ndc11 (package): 67457088701 rxcui: 1000126

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 13 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
199cf13e-0859-4a73-9b45-e700d0cd1049	medroxyPROGESTERone acetate 150 MG in 1 ML Injection [PSN] · 1 ML medroxyprogesterone acetate 150 MG/ML Injection [SCD] · medroxyprogesterone acetate 150 MG per 1 ML Injection [SY]	3	28	These highlights do not include all the information needed to use DEPO-PROVERA CI safely and effectively. See full prescribing information for DEPO-PROVERA CI. DEPO-PROVERA CI (medroxyprogesterone acetate) injectable suspension, for intramuscular use Initial U.S. Approval: 1959	20251218
987496bf-b4b0-409b-b745-f52ed0871f4e	medroxyPROGESTERone acetate 150 MG in 1 ML Injection [PSN] · 1 ML medroxyprogesterone acetate 150 MG/ML Injection [SCD] · medroxyprogesterone acetate 150 MG per 1 ML Injection [SY]	3	10	These highlights do not include all the information needed to use MEDROXYPROGESTERONE ACETATE (MPA) Injectable Suspension, USP safely and effectively. See full prescribing information for MPA INJECTABLE SUSPENSION, USP. MEDROXYPROGESTERONE ACETATE (MPA) Injectable Suspension, USP, for intramuscular use Initial U.S. Approval: 1959	20260107
60aba812-59eb-4d40-9b6b-d135dca9d36b	medroxyPROGESTERone acetate 150 MG in 1 ML Injection [PSN] · 1 ML medroxyprogesterone acetate 150 MG/ML Injection [SCD] · medroxyprogesterone acetate 150 MG per 1 ML Injection [SY]	3	8	These highlights do not include all the information needed to use MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION safely and effectively. See full prescribing information for MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION . MEDROXYPROGESTERONE ACETATE injectable suspension, for intramuscular use Initial U.S. Approval: 1959	20210312
6457d70a-2f25-4935-8511-726d988f7a03	medroxyPROGESTERone acetate 150 MG in 1 ML Injection [PSN] · 1 ML medroxyprogesterone acetate 150 MG/ML Injection [SCD] · medroxyprogesterone acetate 150 MG per 1 ML Injection [SY]	3	7	These highlights do not include all the information needed to use MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION safely and effectively. See full prescribing information for MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION. MEDROXYPROGESTERONE ACETATE injectable suspension, for intramuscular use Initial U.S. Approval: 1959	20260119
91b3473d-b95b-4b7d-a1d4-3ff2cb75a9b9	medroxyPROGESTERone acetate 150 MG in 1 ML Injection [PSN] · 1 ML medroxyprogesterone acetate 150 MG/ML Injection [SCD] · medroxyprogesterone acetate 150 MG per 1 ML Injection [SY]	3	7	These highlights do not include all the information needed to use Medroxyprogesterone Acetate Injectable Suspension, USP safely and effectively. See full prescribing information for Medroxyprogesterone Acetate Injectable Suspension, USP. Medroxyprogesterone Acetate Injectable Suspension, USP, for intramuscular use Initial U.S. Approval: 1959	20110908
24544a5d-0cf5-a099-b57c-6e0843a40532	medroxyPROGESTERone acetate 150 MG in 1 ML Injection [PSN] · 1 ML medroxyprogesterone acetate 150 MG/ML Injection [SCD] · medroxyprogesterone acetate 150 MG per 1 ML Injection [SY]	3	6	These highlights do not include all the information needed to use MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION safely and effectively. See full prescribing information for MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION . MEDROXYPROGESTERONE ACETATE injectable suspension, for intramuscular use Initial U.S. Approval: 1959	20260416
5e817926-ba15-4d16-9463-88f6ff3bd3ac	medroxyPROGESTERone acetate 150 MG in 1 ML Injection [PSN] · 1 ML medroxyprogesterone acetate 150 MG/ML Injection [SCD] · medroxyprogesterone acetate 150 MG per 1 ML Injection [SY]	3	6	These highlights do not include all the information needed to use MEDROXYPROGESTERONE ACETATE (MPA) Injectable Suspension, USP safely and effectively. See full prescribing information for MPA INJECTABLE SUSPENSION, USP. MEDROXYPROGESTERONE ACETATE (MPA) Injectable Suspension, USP, for intramuscular use Initial U.S. Approval: 1959	20260223
d1ea4098-6196-421f-b8e1-bcb31a061e04	medroxyPROGESTERone acetate 150 MG in 1 ML Injection [PSN] · 1 ML medroxyprogesterone acetate 150 MG/ML Injection [SCD] · medroxyprogesterone acetate 150 MG per 1 ML Injection [SY]	3	6	These highlights do not include all the information needed to use MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION safely and effectively. See full prescribing information for MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION. MEDROXYPROGESTERONE ACETATE injectable suspension, for intramuscular use Initial U.S. Approval: 1959	20210629
0655670a-d127-4e08-8a23-ace64b2503b2	medroxyPROGESTERone acetate 150 MG in 1 ML Injection [PSN] · 1 ML medroxyprogesterone acetate 150 MG/ML Injection [SCD] · medroxyprogesterone acetate 150 MG per 1 ML Injection [SY]	3	4	These highlights do not include all the information needed to use MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION safely and effectively. See full prescribing information for MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION. MEDROXYPROGESTERONE ACETATE injectable suspension, for intramuscular use Initial U.S. Approval: 1959	20260108
a80560e1-96dd-4380-b3e1-d52719ccdd4b	medroxyPROGESTERone acetate 150 MG in 1 ML Injection [PSN] · 1 ML medroxyprogesterone acetate 150 MG/ML Injection [SCD] · medroxyprogesterone acetate 150 MG per 1 ML Injection [SY]	3	3	These highlights do not include all the information needed to use MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION safely and effectively. See full prescribing information for MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION. MEDROXYPROGESTERONE ACETATE injectable suspension, for intramuscular use Initial U.S. Approval: 1959	20250207
0476eac5-d96c-4910-aa86-1ddeeefefe50	medroxyPROGESTERone acetate 150 MG in 1 ML Injection [PSN] · 1 ML medroxyprogesterone acetate 150 MG/ML Injection [SCD] · medroxyprogesterone acetate 150 MG per 1 ML Injection [SY]	3	3	These highlights do not include all the information needed to use MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION safely and effectively. See full prescribing information for MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION. MEDROXYPROGESTERONE ACETATE injectable suspension, for intramuscular use Initial U.S. Approval: 1959	20250108
e364a31e-8926-4bda-b00e-efb097bd3830	medroxyPROGESTERone acetate 150 MG in 1 ML Injection [PSN] · 1 ML medroxyprogesterone acetate 150 MG/ML Injection [SCD] · medroxyprogesterone acetate 150 MG per 1 ML Injection [SY]	3	2	These highlights do not include all the information needed to use Medroxyprogesterone acetate Contraceptive Injection safely and effectively. See full prescribing information for Medroxyprogesterone acetate Contraceptive Injection. MEDROXYPROGESTERONE ACETATE injectable suspension, for intramuscular use Initial U.S. Approval: 1959	20221220
cd0bbdb2-754e-4e66-8f36-985b5819d642	medroxyPROGESTERone acetate 150 MG in 1 ML Injection [PSN] · 1 ML medroxyprogesterone acetate 150 MG/ML Injection [SCD] · medroxyprogesterone acetate 150 MG per 1 ML Injection [SY]	3	1	Medroxyprogesterone Acetate Injectable Suspension, USP	20090813

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set ID	Title	Manufacturer	Effective
a0a92717-c1cb-40eb-a95a-1c5dfd32cfc0	These highlights do not include all the information needed to use MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION safely and effectively. See full prescribing information for MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION. MEDROXYPROGESTERONE ACETATE injectable suspension, for intramuscular use Initial U.S. Approval: 1959	REMEDYREPACK INC.	20260904
987496bf-b4b0-409b-b745-f52ed0871f4e	These highlights do not include all the information needed to use MEDROXYPROGESTERONE ACETATE (MPA) Injectable Suspension, USP safely and effectively. See full prescribing information for MPA INJECTABLE SUSPENSION, USP. MEDROXYPROGESTERONE ACETATE (MPA) Injectable Suspension, USP, for intramuscular use Initial U.S. Approval: 1959	Prasco Laboratories \| Pharmacia & Upjohn Company LLC \| Pfizer Manufacturing Belgium NV	20260825
987496bf-b4b0-409b-b745-f52ed0871f4e	These highlights do not include all the information needed to use MEDROXYPROGESTERONE ACETATE (MPA) Injectable Suspension, USP safely and effectively. See full prescribing information for MPA INJECTABLE SUSPENSION, USP. MEDROXYPROGESTERONE ACETATE (MPA) Injectable Suspension, USP, for intramuscular use Initial U.S. Approval: 1959	Prasco Laboratories \| Pharmacia & Upjohn Company LLC \| Pfizer Manufacturing Belgium NV	20260721
24544a5d-0cf5-a099-b57c-6e0843a40532	These highlights do not include all the information needed to use MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION safely and effectively. See full prescribing information for MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION . MEDROXYPROGESTERONE ACETATE injectable suspension, for intramuscular use Initial U.S. Approval: 1959	Xiromed LLC	20260416
5e817926-ba15-4d16-9463-88f6ff3bd3ac	These highlights do not include all the information needed to use MEDROXYPROGESTERONE ACETATE (MPA) Injectable Suspension, USP safely and effectively. See full prescribing information for MPA INJECTABLE SUSPENSION, USP. MEDROXYPROGESTERONE ACETATE (MPA) Injectable Suspension, USP, for intramuscular use Initial U.S. Approval: 1959	A-S Medication Solutions	20260223
24544a5d-0cf5-a099-b57c-6e0843a40532	These highlights do not include all the information needed to use MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION safely and effectively. See full prescribing information for MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION . MEDROXYPROGESTERONE ACETATE injectable suspension, for intramuscular use Initial U.S. Approval: 1959	Xiromed LLC	20260218
24544a5d-0cf5-a099-b57c-6e0843a40532	These highlights do not include all the information needed to use MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION safely and effectively. See full prescribing information for MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION . MEDROXYPROGESTERONE ACETATE injectable suspension, for intramuscular use Initial U.S. Approval: 1959	Xiromed LLC	20260213
6457d70a-2f25-4935-8511-726d988f7a03	These highlights do not include all the information needed to use MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION safely and effectively. See full prescribing information for MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION. MEDROXYPROGESTERONE ACETATE injectable suspension, for intramuscular use Initial U.S. Approval: 1959	Amneal Pharmaceuticals LLC \| Amneal Pharmaceuticals of New York, LLC \| Laboratorios Farmalan, S.A.	20260119
0655670a-d127-4e08-8a23-ace64b2503b2	These highlights do not include all the information needed to use MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION safely and effectively. See full prescribing information for MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION. MEDROXYPROGESTERONE ACETATE injectable suspension, for intramuscular use Initial U.S. Approval: 1959	Eugia US LLC \| EUGIA Pharma Specialities Limited	20260108
987496bf-b4b0-409b-b745-f52ed0871f4e	These highlights do not include all the information needed to use MEDROXYPROGESTERONE ACETATE (MPA) Injectable Suspension, USP safely and effectively. See full prescribing information for MPA INJECTABLE SUSPENSION, USP. MEDROXYPROGESTERONE ACETATE (MPA) Injectable Suspension, USP, for intramuscular use Initial U.S. Approval: 1959	Prasco Laboratories \| Pharmacia & Upjohn Company LLC \| Pfizer Manufacturing Belgium NV	20260107
fda1aa8a-5739-482a-b4f6-9741ef4d9977	These highlights do not include all the information needed to use MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION USP safely and effectively. See full prescribing information for MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION USP. MEDROXYPROGESTERONE ACETATE injectable suspension, for intramuscular use Initial U.S. Approval: 1959	Amphastar Pharmaceuticals, Inc.	20260101
a0a92717-c1cb-40eb-a95a-1c5dfd32cfc0	These highlights do not include all the information needed to use MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION safely and effectively. See full prescribing information for MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION. MEDROXYPROGESTERONE ACETATE injectable suspension, for intramuscular use Initial U.S. Approval: 1959	REMEDYREPACK INC.	20251002
a80560e1-96dd-4380-b3e1-d52719ccdd4b	These highlights do not include all the information needed to use MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION safely and effectively. See full prescribing information for MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION. MEDROXYPROGESTERONE ACETATE injectable suspension, for intramuscular use Initial U.S. Approval: 1959	Amneal Pharmaceuticals NY LLC \| Senador Laboratories Private Limited	20250207
0476eac5-d96c-4910-aa86-1ddeeefefe50	These highlights do not include all the information needed to use MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION safely and effectively. See full prescribing information for MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION. MEDROXYPROGESTERONE ACETATE injectable suspension, for intramuscular use Initial U.S. Approval: 1959	Hikma Pharmaceuticals USA Inc.	20250108
428481bb-b7cf-4d76-b57d-0d6bfa2b6ac3	These highlights do not include all the information needed to use MEDROXYPROGESTERONE ACETATE (MPA) Injectable Suspension, USP safely and effectively. See full prescribing information for MPA INJECTABLE SUSPENSION, USP. MEDROXYPROGESTERONE ACETATE (MPA) Injectable Suspension, USP, for intramuscular use Initial U.S. Approval: 1959	Greenstone LLC \| Pfizer Manufacturing Belgium NV \| Pharmacia & Upjohn Company LLC	20240816
d4d27703-5ad0-4ead-9481-0aba2fa1b45c	These highlights do not include all the information needed to use MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION safely and effectively. See full prescribing information for MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION. MEDROXYPROGESTERONE ACETATE injectable suspension, for intramuscular use Initial U.S. Approval: 1959	Bryant Ranch Prepack	20230315
d415e7cc-0756-4c70-803f-011133a6b731	These highlights do not include all the information needed to use MEDROXYPROGESTERONE ACETATE (MPA) Injectable Suspension, USP safely and effectively. See full prescribing information for MPA INJECTABLE SUSPENSION, USP. MEDROXYPROGESTERONE ACETATE (MPA) Injectable Suspension, USP, for intramuscular use Initial U.S. Approval: 1959	A-S Medication Solutions	20230206
a67023c9-9927-4333-aa88-00804db36570	These highlights do not include all the information needed to use Medroxyprogesterone acetate Contraceptive Injection safely and effectively. See full prescribing information for Medroxyprogesterone acetate Contraceptive Injection. MEDROXYPROGESTERONE ACETATE injectable suspension, for intramuscular use Initial U.S. Approval: 1959	A-S Medication Solutions	20230206
e364a31e-8926-4bda-b00e-efb097bd3830	These highlights do not include all the information needed to use Medroxyprogesterone acetate Contraceptive Injection safely and effectively. See full prescribing information for Medroxyprogesterone acetate Contraceptive Injection. MEDROXYPROGESTERONE ACETATE injectable suspension, for intramuscular use Initial U.S. Approval: 1959	Amphastar Pharmaceuticals, Inc.	20221220
d279981c-e9e4-4989-bafb-1e184a6d3dd2	These highlights do not include all the information needed to use MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION safely and effectively. See full prescribing information for MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION. MEDROXYPROGESTERONE ACETATE injectable suspension, for intramuscular use Initial U.S. Approval: 1959	Teva Parenteral Medicines, Inc.	20220930
fda1aa8a-5739-482a-b4f6-9741ef4d9977	These highlights do not include all the information needed to use Medroxyprogesterone acetate Contraceptive Injection safely and effectively. See full prescribing information for Medroxyprogesterone acetate Contraceptive Injection. MEDROXYPROGESTERONE ACETATE injectable suspension, for intramuscular use Initial U.S. Approval: 1959	Amphastar Pharmaceuticals, Inc.	20211213
7cc31691-8268-4e59-b645-19246931f03c	These highlights do not include all the information needed to use MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION safely and effectively. See full prescribing information for MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION. MEDROXYPROGESTERONE ACETATE injectable suspension, for intramuscular use Initial U.S. Approval: 1959	NorthStar RxLLC \| Sun Pharmaceutical Industries, Inc. \| Sun Pharmaceutical Industries Limited	20210630
d1ea4098-6196-421f-b8e1-bcb31a061e04	These highlights do not include all the information needed to use MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION safely and effectively. See full prescribing information for MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION. MEDROXYPROGESTERONE ACETATE injectable suspension, for intramuscular use Initial U.S. Approval: 1959	Sun Pharmaceutical Industries, Inc. \| Sun Pharmaceutical Industries Limited	20210629
60aba812-59eb-4d40-9b6b-d135dca9d36b	These highlights do not include all the information needed to use MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION safely and effectively. See full prescribing information for MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION . MEDROXYPROGESTERONE ACETATE injectable suspension, for intramuscular use Initial U.S. Approval: 1959	Mylan Institutional LLC	20210312
7cff8b17-0468-68ba-e053-2991aa0af484	These highlights do not include all the information needed to use Medroxyprogesterone acetate Contraceptive Injection safely and effectively. See full prescribing information for Medroxyprogesterone acetate Contraceptive Injection. MEDROXYPROGESTERONE ACETATE injectable suspension, for intramuscular use Initial U.S. Approval: 1959	NuCare Pharmaceuticals,Inc.	20210217
3d033fba-6313-4906-9d34-245423eaeeef	These highlights do not include all the information needed to use MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION safely and effectively. See full prescribing information for MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION MEDROXYPROGESTERONE ACETATE, injectable suspension, for intramuscular use Initial U.S. Approval:1959	Cipla USA Inc. \| Cipla Ltd.- Goa \| Farmabios S.p.A.	20201230
50a4a646-99be-4a0e-a8c0-e6fb364d6c67	These highlights do not include all the information needed to use MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION safely and effectively. See full prescribing information for MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION. MEDROXYPROGESTERONE ACETATE injectable suspension, for intramuscular use Initial U.S. Approval: 1959	Northstar RxLLC	20201230
9451ca1a-34a4-46e2-bacc-6268a2f60bc8	These highlights do not include all the information needed to use MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION safely and effectively. See full prescribing information for MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION. MEDROXYPROGESTERONE ACETATE injectable suspension, for intramuscular use Initial U.S. Approval: 1959	Proficient Rx LP	20191001
664b355e-4fc0-596f-e053-2a91aa0a3ceb	These highlights do not include all the information needed to use MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION safely and effectively. See full prescribing information for MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION. MEDROXYPROGESTERONE ACETATE injectable suspension, for intramuscular use Initial U.S. Approval: 1959	NuCare Pharmaceuticals,Inc.	20180904
8ad58c4b-c263-4562-92cd-b1f81f3e06b3	These highlights do not include all the information needed to use MEDROXYPROGESTERONE ACETATE (MPA) Injectable Suspension, USP safely and effectively. See full prescribing information for MPA INJECTABLE SUSPENSION, USP. MEDROXYPROGESTERONE ACETATE (MPA) Injectable Suspension, USP, for intramuscular use Initial U.S. Approval: 1959	REMEDYREPACK INC.	20180814
9f0ac808-3768-4f74-95ed-95fa1b27f58e		National Council for Prescription Drug Programs	20120724
ba469085-492f-4bb0-835c-bb616a688535		National Council for Prescription Drug Programs	20120724
8ed1c691-0ff8-4992-9070-763cd328d8bf		National Council for Prescription Drug Programs	20120724
8b9a0d28-14f2-48e1-851f-6b2b5b02df4b		National Council for Prescription Drug Programs	20120724
d9973224-9c97-4b68-b5be-ddb6c0f206c6		National Council for Prescription Drug Programs	20120724
837b1e6c-6af1-4c25-ae4c-2b84e31ecf80		National Council for Prescription Drug Programs	20120724
4aad03e5-dbf0-4b4e-a937-7b550cba0fc9		National Council for Prescription Drug Programs	20120724
fdb47ab8-b0b3-4f05-a539-c17df63e843a		National Council for Prescription Drug Programs	20120724
91b3473d-b95b-4b7d-a1d4-3ff2cb75a9b9	These highlights do not include all the information needed to use Medroxyprogesterone Acetate Injectable Suspension, USP safely and effectively. See full prescribing information for Medroxyprogesterone Acetate Injectable Suspension, USP. Medroxyprogesterone Acetate Injectable Suspension, USP, for intramuscular use Initial U.S. Approval: 1959	Preferred Pharmaceuticals, Inc	20110908
cd0bbdb2-754e-4e66-8f36-985b5819d642	Medroxyprogesterone Acetate Injectable Suspension, USP	Physicians Total Care, Inc.	20090813

Drug Classes#

Source, Class ID, Class table
Source	Class ID	Class	Type	Relationship	Drug concept
ATC	G03DA	Pregnen (4) derivatives	ATC1-4		medroxyprogesterone
ATC	L02AB	Progestogens	ATC1-4		medroxyprogesterone
ATC	G03AC	Progestogens	ATC1-4		medroxyprogesterone
FDASPL	D045167	Progesterone Congeners	CHEM	has_chemical_structure	medroxyprogesterone
FDASPL	N0000175602	Progestin	EPC	has_epc	medroxyprogesterone
MEDRT	D008525	Medroxyprogesterone	CHEM	has_ingredient	medroxyprogesterone
MEDRT	D017258	Medroxyprogesterone Acetate	CHEM	has_ingredient	medroxyprogesterone acetate
MEDRT	D000568	Amenorrhea	DISEASE	may_treat	medroxyprogesterone acetate
MEDRT	D000568	Amenorrhea	DISEASE	may_treat	medroxyprogesterone
MEDRT	D001943	Breast Neoplasms	DISEASE	may_treat	medroxyprogesterone
MEDRT	D001943	Breast Neoplasms	DISEASE	ci_with	medroxyprogesterone
MEDRT	D001943	Breast Neoplasms	DISEASE	ci_with	medroxyprogesterone acetate
MEDRT	D001943	Breast Neoplasms	DISEASE	may_treat	medroxyprogesterone acetate
MEDRT	D002292	Carcinoma, Renal Cell	DISEASE	may_treat	medroxyprogesterone acetate
MEDRT	D002292	Carcinoma, Renal Cell	DISEASE	may_treat	medroxyprogesterone
MEDRT	D002543	Cerebral Hemorrhage	DISEASE	ci_with	medroxyprogesterone acetate
MEDRT	D002543	Cerebral Hemorrhage	DISEASE	ci_with	medroxyprogesterone
MEDRT	D004342	Drug Hypersensitivity	DISEASE	ci_with	medroxyprogesterone acetate
MEDRT	D004342	Drug Hypersensitivity	DISEASE	ci_with	medroxyprogesterone
MEDRT	D004714	Endometrial Hyperplasia	DISEASE	may_treat	medroxyprogesterone acetate
MEDRT	D004714	Endometrial Hyperplasia	DISEASE	may_treat	medroxyprogesterone
MEDRT	D016889	Endometrial Neoplasms	DISEASE	may_treat	medroxyprogesterone
MEDRT	D016889	Endometrial Neoplasms	DISEASE	may_treat	medroxyprogesterone acetate
MEDRT	D006470	Hemorrhage	DISEASE	ci_with	medroxyprogesterone
MEDRT	D006470	Hemorrhage	DISEASE	ci_with	medroxyprogesterone acetate
MEDRT	D007040	Hypoventilation	DISEASE	may_treat	medroxyprogesterone
MEDRT	D007040	Hypoventilation	DISEASE	may_treat	medroxyprogesterone acetate
MEDRT	D008107	Liver Diseases	DISEASE	ci_with	medroxyprogesterone acetate
MEDRT	D008107	Liver Diseases	DISEASE	ci_with	medroxyprogesterone
MEDRT	D009376	Neoplasms, Hormone-Dependent	DISEASE	ci_with	medroxyprogesterone acetate
MEDRT	D009376	Neoplasms, Hormone-Dependent	DISEASE	ci_with	medroxyprogesterone
MEDRT	D011247	Pregnancy	DISEASE	may_prevent	medroxyprogesterone acetate
MEDRT	D011247	Pregnancy	DISEASE	may_prevent	medroxyprogesterone
MEDRT	D011247	Pregnancy	DISEASE	ci_with	medroxyprogesterone
MEDRT	D011247	Pregnancy	DISEASE	ci_with	medroxyprogesterone acetate
MEDRT	D011655	Pulmonary Embolism	DISEASE	ci_with	medroxyprogesterone acetate
MEDRT	D011655	Pulmonary Embolism	DISEASE	ci_with	medroxyprogesterone
MEDRT	D013924	Thrombophlebitis	DISEASE	ci_with	medroxyprogesterone acetate
MEDRT	D013924	Thrombophlebitis	DISEASE	ci_with	medroxyprogesterone
MEDRT	D014592	Uterine Hemorrhage	DISEASE	ci_with	medroxyprogesterone
MEDRT	D014592	Uterine Hemorrhage	DISEASE	ci_with	medroxyprogesterone acetate
MEDRT	D014592	Uterine Hemorrhage	DISEASE	may_treat	medroxyprogesterone acetate
MEDRT	D014592	Uterine Hemorrhage	DISEASE	may_treat	medroxyprogesterone
MEDRT	D014623	Vaginal Diseases	DISEASE	ci_with	medroxyprogesterone
MEDRT	D014623	Vaginal Diseases	DISEASE	ci_with	medroxyprogesterone acetate
MEDRT	D020246	Venous Thrombosis	DISEASE	ci_with	medroxyprogesterone
MEDRT	D020246	Venous Thrombosis	DISEASE	ci_with	medroxyprogesterone acetate
MEDRT	N0000000185	Progestational Hormone Receptor Agonists	MOA	has_moa	medroxyprogesterone acetate
MEDRT	N0000000185	Progestational Hormone Receptor Agonists	MOA	has_moa	medroxyprogesterone
MEDRT	N0000008630	Decreased Follicle Stimulating Hormone Secretion	PE	has_pe	medroxyprogesterone acetate
MEDRT	N0000008630	Decreased Follicle Stimulating Hormone Secretion	PE	has_pe	medroxyprogesterone
MEDRT	N0000008632	Decreased Growth Hormone Secretion	PE	has_pe	medroxyprogesterone acetate
MEDRT	N0000008632	Decreased Growth Hormone Secretion	PE	has_pe	medroxyprogesterone
MEDRT	N0000009051	Gonadotropin Releasing Hormone Alteration	PE	has_pe	medroxyprogesterone acetate
MEDRT	N0000009051	Gonadotropin Releasing Hormone Alteration	PE	has_pe	medroxyprogesterone
MEDRT	N0000009715	Inhibit Ovarian Follicular Phase	PE	has_pe	medroxyprogesterone acetate
MEDRT	N0000009715	Inhibit Ovarian Follicular Phase	PE	has_pe	medroxyprogesterone
MEDRT	N0000009717	Inhibit Ovulation	PE	has_pe	medroxyprogesterone acetate
MEDRT	N0000009717	Inhibit Ovulation	PE	has_pe	medroxyprogesterone
MEDRT	N0000009857	Stimulate Breast Glandular Development	PE	has_pe	medroxyprogesterone acetate
MEDRT	N0000009857	Stimulate Breast Glandular Development	PE	has_pe	medroxyprogesterone
MEDRT	N0000000043	Hepatic Excretion	PK	has_pk	medroxyprogesterone
MEDRT	N0000000043	Hepatic Excretion	PK	has_pk	medroxyprogesterone acetate
MEDRT	N0000000026	Hepatic Metabolism	PK	has_pk	medroxyprogesterone
MEDRT	N0000000026	Hepatic Metabolism	PK	has_pk	medroxyprogesterone acetate
MEDRT	N0000000042	Renal Excretion	PK	has_pk	medroxyprogesterone
MEDRT	N0000000042	Renal Excretion	PK	has_pk	medroxyprogesterone acetate

Group, Type, Concept table
Group	Type	Concept	Source
BN	BN	Depo-Provera	rxnav_allrelated
DF	DF	Injection	rxnav_allrelated
DFG	DFG	Injectable Product	rxnav_allrelated
IN	IN	medroxyprogesterone	rxnav_allrelated
PIN	PIN	medroxyprogesterone acetate	rxnav_allrelated
SBD	SBD	1 ML medroxyprogesterone acetate 150 MG/ML Injection [Depo-Provera]	rxnav_allrelated
SBDC	SBDC	medroxyprogesterone acetate 150 MG/ML [Depo-Provera]	rxnav_allrelated
SBDF	SBDF	medroxyprogesterone Injection [Depo-Provera]	rxnav_allrelated
SBDFP	SBDFP	medroxyprogesterone acetate Injection [Depo-Provera]	rxnav_allrelated
SBDG	SBDG	Depo-Provera Injectable Product	rxnav_allrelated
SCD	SCD	1 ML medroxyprogesterone acetate 150 MG/ML Injection	rxnav_allrelated
SCDC	SCDC	medroxyprogesterone acetate 150 MG/ML	rxnav_allrelated
SCDF	SCDF	medroxyprogesterone Injection	rxnav_allrelated
SCDFP	SCDFP	medroxyprogesterone acetate Injection	rxnav_allrelated
SCDG	SCDG	medroxyprogesterone Injectable Product	rxnav_allrelated
SCDGP	SCDGP	medroxyprogesterone acetate Injectable Product	rxnav_allrelated

Properties#

Category, Property, Value table
Category	Property	Value
ATTRIBUTES	AVAILABLE_STRENGTH	150 MG/ML (expressed as medroxyprogesterone acetate)
ATTRIBUTES	GENERAL_CARDINALITY	SINGLE
ATTRIBUTES	HUMAN_DRUG	US
ATTRIBUTES	QUANTITY	1 ML
ATTRIBUTES	RXNAV_HUMAN_DRUG	US
ATTRIBUTES	SCHEDULE	0
CODES	ANDA	ANDA077235
CODES	ANDA	ANDA210227
CODES	ANDA	ANDA210760
CODES	ANDA	ANDA212824
CODES	ANDA	ANDA214309
CODES	ANDA	ANDA215397
CODES	VUID	4002357
NAMES	Prescribable Synonym	medroxyPROGESTERone acetate 150 MG in 1 ML Injection
NAMES	Tallman Synonym	1 ML medroxyPROGESTERone acetate 150 MG/ML Injection
NAMES	Tallman Synonym	medroxyPROGESTERone acetate 150 MG per 1 ML Injection
SOURCES	Source	Gold Standard Alchemy
SOURCES	Source	Metathesaurus FDA Structured Product Labels
SOURCES	Source	Micromedex RED BOOK
SOURCES	Source	Multum MediSource Lexicon
SOURCES	Source	National Drug Data File Plus Source Vocabulary
SOURCES	Source	Veterans Health Administration National Drug File